Biopharmaceutical therapies for rare pediatric diseases
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2021 | PTC THERAPEUTICS, INC. |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | $190,000 | |
| 2021 | PTC THERAPEUTICS, INC. |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | $300,000 | |
| 2021 | PTC THERAPEUTICS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $180,000 | |
| 2021 | PTC THERAPEUTICS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $180,000 | |
| 2021 | PTC THERAPEUTICS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $180,000 | |
| 2021 | PTC THERAPEUTICS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $180,000 |
| Client | Filings | Total Income |
|---|---|---|
| PTC THERAPEUTICS, INC. | 38 | — |
| Name | Disclosed Prior Position |
|---|---|
| BRITTANY ARGOTE | |
| NICHOLAS BRAUGHTON | |
| JONATHAN REA MCPHERSON | |
| LEAH DUFFY SVOBODA |